Alpharetta Newswire

Comprehensive Real-Time News Feed for Alpharetta, GA.

Results 1 - 20 of 29 for "u:freshnews.com" in Alpharetta, GA

  1. Clearside Biomedical, Inc. to Report Efficacy and Safety Results in...Read the original story

    Thursday Apr 30 | Freshnews

    Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced that results from their Phase 1/2 clinical trial will be presented at the 2015 Annual Meeting of the Association for Research and Vision in Ophthalmology , May 3-7, 2015, in Denver, CO. Debra Goldstein, MD, Professor of Ophthalmology and Director, Uveitis Service, at the Northwestern University Feinberg School of Medicine will present the results of the six-month clinical trial: A Phase 1/2 Open-Label, Safety and Tolerability Study of Triamcinolone Acetonide Administered to the Suprachoroidal Space in Patients with Non-Infectious Uveitis.

    Comment?

  2. Spark Therapeutics and Clearside Biomedical Announce Exclusive Option ...Read the original story

    Tuesday Apr 28 | Freshnews

    Spark Therapeutics, Inc. and Clearside Biomedical, Inc. announced today that they have entered into an option agreement under which Spark acquired exclusive rights to license Clearside's microinjector technology to deliver gene therapies to the back of the eye. Under the agreement, the companies will explore the feasibility of using Clearside's microinjector technology to deliver viral vectors to the choroid and the retina through the suprachoroidal space .

    Comment?

  3. Alimera Sciences to Release First Quarter 2015 Financial ResultsRead the original story

    Tuesday Apr 28 | Freshnews

    Alimera Sciences, Inc. , a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its first quarter 2015 financial results after the market close on Thursday, May 7, 2015. An investor conference call will follow on the same day at 4:30 p.m. ET.

    Comment?

  4. Clearside Biomedical, Inc. Announces Purchase of iScience Patent...Read the original story

    Wednesday Apr 22 | Freshnews

    Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the purchase and acquisition of iScience Interventional Corporation's patent portfolio covering drug delivery to the suprachoroidal space . The iScience SCS patent portfolio includes United States and international patents and patent applications.

    Comment?

  5. DH2i to Present 'Standalone to High Availability Clusters Over Lunch...Read the original story

    Mar 31, 2015 | Freshnews

    DH2i , the leading provider of Windows Server application portability and management solutions, today announced it will present a talk entitled, "Standalone to High Availability Clusters Over Lunch -- with Time to Spare," during upcoming PASS SQLSaturday events taking place in Cambridge, Massachusetts and Alpharetta, Georgia.

    Comment?

  6. Agilysys Named a 'Top 40' Innovative Technology Company by...Read the original story

    Mar 19, 2015 | Freshnews

    Agilysys, Inc. , a leading provider of innovative hospitality software solutions and services, has announced that the Technology Association of Georgia , the state's leading association dedicated to the promotion and economic advancement of Georgia's technology industry, has named Agilysys as one of its Top 40 Innovative Technology Companies in Georgia. TAG will recognize the group at the 2015 Georgia Technology Summit, on March 25, at Cobb Galleria Centre in Atlanta.

    Comment?

  7. Alimera Sciences to Host Analyst and Investor Luncheon on Wednesday, March 25, 2015 in New York CityRead the original story

    Mar 19, 2015 | Freshnews

    Alimera Sciences, Inc. , a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it will host an Analyst and Investor Luncheon on Wednesday, March 25, 2015 in New York City. Dan Myers, Chief Executive Officer, and Rick Eiswirth, Chief Financial Officer, will be joined by Key Opinion Leaders to discuss the U.S. commercial launch of ILUVIEN, the Company's sustained release intravitreal implant used to treat patients with diabetic macular edema.

    Comment?

  8. Agilysys and Compass Group North America Expand Partnership with...Read the original story w/Photo

    Mar 3, 2015 | Freshnews

    ALPHARETTA, Ga. & CHARLOTTE, N.C. -- -- Agilysys, Inc. , a leading provider of innovative hospitality software solutions, and Compass Group North America , a leader in foodservice management and support services, today announced an expansion of their technology partnership as Compass Group becomes the first foodservice management customer to implement the InfoGenesis Flex mobile point-of-sale system combined with the rGuest Pay payment gateway application.

    Comment?

  9. Clearside Biomedical, Inc. Initiates Phase 2 Clinical Trial to...Read the original story

    Mar 2, 2015 | Freshnews

    Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the enrollment of the first patient in a Phase 2 randomized, controlled, masked, multi-center clinical trial for the treatment of macular edema associated with retinal vein occlusion using Clearside's proprietary formulation of triamcinolone acetonide, CLS-TA, administered via suprachoroidal injection using Clearside's proprietary microinjector.

    Comment?

  10. Carter Validus Mission Critical REIT, Inc. Acquires $76.9 Million in...Read the original story

    Feb 13, 2015 | Freshnews

    Carter Validus Mission Critical REIT, Inc. acquired the Alpharetta Data Center II property for $56.7 million in the fourth quarter of 2014, and the Landmark Hospital of Savannah property for $20.2 million in January 2015. Alpharetta Data Center II is a 165,000-square-foot enterprise data center facility located in Alpharetta, Georgia.

    Comment?

  11. ViveBio, LLC Enters Worldwide Exclusive Licensing Agreement with...Read the original story

    Feb 10, 2015 | Freshnews

    ViveBio, LLC announced today that it has signed a worldwide exclusive licensing agreement with Renovar, Inc. for urine based biomarkers to predict and monitor kidney diseases as well as rejection in transplant recipients. Based upon unique inflammatory protein signatures found in the urine of diseased or injured kidney's, the Renovar technology can be used to assess the health of a patients kidney's, guide therapeutic decision making and help stratify patients by risk for developing acute rejection.

    Comment?

  12. Alimera Sciences' ILUVIENA Receives Marketing Authorization in Finland and LuxembourgRead the original story

    Jan 26, 2015 | Freshnews

    Alimera Sciences, Inc. , a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that marketing authorization has been granted by the Finnish Medicines Agency in Finland and the Ministry of Health in Luxembourg to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema considered insufficiently responsive to available therapies. Approvals in Finland and Luxembourg mark the 14th and 15th European approvals through the Repeat-Use application procedure.

    Comment?

  13. Agilysys to Report Fiscal 2015 Third Quarter Results on February 4...Read the original story

    Jan 22, 2015 | Freshnews

    Agilysys, Inc. , a leading provider of innovative information technology and hospitality software and services, announced today that it will release its fiscal 2015 third quarter results before the market opens on Wednesday, February 4, 2015 and will host a conference call and webcast at 9:00 a.m. ET on Wednesday, February 4. Both the call and webcast are open to the general public. The conference call number is 224-357-2393 .

    Comment?

  14. Clearside Biomedical, Inc. Initiates Phase 2 Clinical Trial For the...Read the original story

    Jan 5, 2015 | Freshnews

    Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the enrollment of the first patient in a Phase 2 randomized, controlled, masked, multi-center clinical trial for the treatment of macular edema associated with non-infectious uveitis using Clearside's proprietary formulation of triamcinolone acetonide, CLS-TA, administered via suprachoroidal injection using Clearside's proprietary microinjector. Approximately 30 patients will be randomized 1:1 to receive either a single 4.0 mg dose or a single lower dose of 0.8 mg of CLS-TA.

    Comment?

  15. Georgia Bio Deals of the Year Spotlight Financings, Acquisitions and CollaborationRead the original story

    Dec 19, 2014 | Freshnews

    Georgia Bio announced its 2015 Deals of the Year for pharmaceutical, biotechnology, healthcare IT and medical device companies in three categories - private financing, acquisitions and public/private collaboration - reflecting a broad range of activity. The annual Deal of the Year awards recognize transactions by life sciences companies in Georgia such as financings, partnering agreements and government grants that are significant to the state's industry development.

    Comment?

  16. Xpanxion Continues Growth in Nebraska with New Location in LincolnRead the original story

    Dec 15, 2014 | Freshnews

    The software services firm Xpanxion has continued to expand its operations in the state of Nebraska by opening a new office location in the downtown Haymarket District of Lincoln. The company has had presence in the state since 2006 and already operates two locations in Kearney along with a location in Loup City. 1 comment

  17. Ryder Achieves Biggest Employee Campaign Results to Date for United WayRead the original story

    Dec 10, 2014 | Freshnews

    Ryder System, Inc. , a leader in commercial fleet management and supply chain solutions , is proud to announce it has surpassed its 2014 United Way Campaign goal, with a total contribution of $700,000, constituting Ryder's largest contribution and record setting employee pledge total to the United Way to date. Funds raised through the annual campaign are invested in programs and initiatives that prepare children and youth for success in school and life, help individuals and families pave a path to financial stability, and offer health screenings and resources that help individuals, families, and older adults improve their health.

    Comment?

  18. Agilysys Promotes Jaddi to SVP of Customer Support & Service SolutionsRead the original story

    Dec 9, 2014 | Freshnews

    Agilysys, Inc. , a leading provider of innovative information technology and hospitality software and services, today announced the promotion of Rehan Jaddi to senior vice president of customer support & service solutions, effective immediately. Jaddi previously served as vice president of product development engineering at Agilysys.

    Comment?

  19. CSI Laboratories Breaks Ground on Multimillion-Dollar Molecular LaboratoryRead the original story

    Dec 1, 2014 | Freshnews

    CSI Laboratories, a private national reference laboratory specializing in cancer diagnostics, announced today that construction has begun on the expansion plan that will modify its current operational structure to include a molecular laboratory at the company's 65,000 square foot facility in Alpharetta, GA . The addition of a molecular laboratory comes just three years after CSI opened its state-of-the art facility on Westside Parkway.

    Comment?

  20. Alimera Sciences' ILUVIENA Receives Marketing Authorization In...Read the original story

    Dec 1, 2014 | Freshnews

    Alimera Sciences, Inc. , a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Dutch Inspectie voor de Gezondheidszorg has granted marketing authorization in the Netherlands to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema considered insufficiently responsive to available therapies.

    Comment?

Alpharetta Job Listings
View or post Alpharetta job listings on Topix.
Alpharetta Real Estate
News, listings, and foreclosures in Alpharetta from Topix.
Alpharetta Mortgages
Find mortgage rates in Alpharetta on Topix.